Frontiers in Oncology reviews tumor immunosenescence mechanisms and emerging senotherapeutic strategies in breast cancer
A newly published review synthesizes how age-associated immune decline and cellular senescence drive breast cancer progression, establishing metabolic rescue and targeted senolytics as promising clinical frontiers.
Read analysis